Assembly Bill 3129 would have given the California Attorney General oversight of all private equity investments or purchases involving a healthcare entity. Gov. Gavin Newsom argued that a similar regulatory framework is already in place. 

Experts are calling the agent “the most exciting development in the field of nuclear cardiology" in several decades.

ShortCut, which gained the FDA’s breakthrough device designation back in January, is used to split valve leaflets and reduce the risk of obstruction.

Quebec-headquartered imaging solutions provider Christie Innomed is fighting the deal in court, claiming the bidding process was unfair. 

Specialty societies such as the American College of Radiology are asking lawmakers to reform the federal payment program to end years of negative updates. 

Pinnacle Health Services and Duke are arguing in court over their ability to add additional MRI services in Wake County, North Carolina. 

The drugmaker is voluntarily withdrawing Oxbryta from the market due to a higher-than-acceptable risk of death.

A federal judge in California ruled existing evidence of the negative effects of fluoride in drinking water warrants an investigation and potential action from the Environmental Protection Agency.